Anti-CD25/IL2RA antibody [EBS-CD-017] (STJ16101100)

SKU:
STJ16101100
£308.50 - £1,349.50
Free Shipping
Processing The item has been added

Short Description :Mouse monoclonal anti-CD25/IL2RA for use in ELISA, FC, IF and IHC in Human samples. Datasheet included with dilution recommendations, and related reagents.
Applications:ELISA/FC/IF/IHC
Host:Mouse
Reactivity:Human
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality :Monoclonal
Clone ID :EBS-CD-017
Isotype:IgG2ak
Conjugation:Unconjugated
Concentration:Can be provided as 100 µg/mL, 500 µg/mL or 1mg/mL.
Purification:Affinity purified from tissue culture.
Dilution Range:ELISA (solid phase: 0, 1-100 µg/ml; tracer: 0, 001-100 µg/ml for 30 min at RT). Flow Cytometry (1-2 Mu g/million cells in 0, 1 ml for 30 min, at 4°C). Immunofluorescence (1-2 Mu g/ml). Immunohistology (1-2 Mu g/ml for 30 min at RT; no suitable antige
Formulation:PBS with 0.02% Sodium Azide.
Storage Instruction:Store for up to 1 year at 2-8°C upon receipt.
Immunogen:A BALB/c mouse was immunized with human PBMCs. Fusion partner: Sp2/0.
Background EBS-CD-017 reacts with CD25 (55 kDa) which associates as alpha chain with CD122 and the common gamma chain (CD132) to form the high-affinity IL-2 receptor complex. With respect to lymphomas, CD25 is present on malignant cells of Hodgkin s disease, HTLV-1+ adult T-cell leukemia, cutaneous T-cell lymphoma, and hairy cell leukemia. Increased levels of soluble CD25 are observed in leukemias/lymphomas and inflammatory/autoimmune diseases. CD25 alone appears to function as a low affinity receptor and associates with CD122 (IL-2R chain, p75) and CD132 (common chain) to form the high affinity IL-2 receptor complex. CD25 antibodies detect three epitope regions, A, B and C. EBS-CD-017 recognizes B epitope, which is located at residue 3-104 of CD25 and does not block IL-2 binding to CD25. CD25 antibodies have been used successfully as a carrier for cytotoxic drugs enabling specific delivery to IL-2RA displaying target cells.

Information sourced from Uniprot.org